-

COVID-19 Vaccine Developments Subscription: Therapeutics Experiments and Diagnostics/Devices Advances - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "COVID-19 - Vaccine Development, Therapeutics Experiments and Diagnostics/devices advances - Premium Bundle" report has been added to ResearchAndMarkets.com's offering.

The COVID-19 - Vaccine Development, Therapeutics Experiments and Diagnostics/devices advances - Premium Bundle includes:

  • Subscription to 6 Dailies
  • Subscription to 6 Weekly Summary Reports
  • Subscription to 6 Monthly Synthesis Reports

Choices available to choose from:

Daily: 27 Daily reports available

To choose one Daily report from the available Categories, Regions, Healthcare sub-industries and Market capitalization levels

Weekly: 15 Weekly summary reports available

To choose one Weekly summary report from the available Categories, Regions, Healthcare sub-industries and Market capitalization levels

Monthly: 22 Monthly synthesis reports available

To choose one Monthly report from the available sub-categories within each of the three categories

Key Topics Covered:

Coverage - Daily Reports:

  • Daily report offer at five different time zones, daily updates for 20+ global news each related to COVID-19 Vaccine Development, Therapeutics Experiments, and Diagnostics/Devices Advances, comprehensively compiled and curated from global as well as regional and local news media.
  • Daily report offers 20+ COVID-19 business news for the last 24-48 hours, comprehensively compiled and curated from regional and local news media, and summarized succinctly for each of the 4 key regions - Americas, Asia, Emerging Markets, and Europe
  • Daily report offers 20+ COVID-19 business news for the last 24-48 hours, comprehensively compiled and curated from regional and local news media, and summarized succinctly for each of the 4 healthcare sub-industries - Biotechnology, Healthcare Services, Medical Devices, and Pharmaceuticals
  • Daily report offers 20+ COVID-19 business news for the last 24-48 hours, comprehensively compiled and curated from regional and local news media, and summarized succinctly for each of the 4 market capitalization levels - LargeCap Companies, Small-MidCap Companies, Privately-Owned Companies, and Non-Profit Organizations

Coverage - Weekly Summary Reports:

  • A weekly presentation of all the recent crucial development related to COVID-19 Vaccine Development, Therapeutics Experiments, and Diagnostics/Devices Advances
  • Recent crucial development of the week relevant to COVID-19 business news related to Vaccine Development, Therapeutics Experiments, and Diagnostics/Devices Advances for American, Asian, Emerging Market, and European companies, research institutes, academia, and healthcare organizations rounded up and summarized succinctly to present a complete overview of the current happenings
  • Recent crucial development of the week relevant to COVID-19 business news related to Vaccine Development, Therapeutics Experiments, and Diagnostics/Devices Advances for Biotechnology, Healthcare Services, Medical Devices, and Pharmaceutical companies worldwide rounded up and summarized succinctly to present a complete overview of the current happenings
  • Recent crucial development of the week relevant to COVID-19 business news related to Vaccine Development, Therapeutics Experiments, and Diagnostics/Devices Advances for LargeCap, Small-MidCap, and Privately-owned companies, and Non-Profit organizations worldwide rounded up and summarized succinctly to present a complete overview of the current happenings

Coverage - Monthly Synthesis Reports:

  • A monthly overview on key updates with analysis offered for each of the different sub-categories of Vaccine Development such as Clinical/Human Trials, Global Grants/Funding, Licensing, Manufacturing/Purchasing/Selling, Regulatory Approvals, and Research/Studies
  • A monthly overview on key updates with analysis offered for each of the different sub-categories of Therapeutics Experiments such as Clinical Trials, Global Grants/Funding, Existing Medicines Research, Licensing, Manufacturing/Production/Selling, Regulatory Approvals, Research/Studies, and Treatment/Therapies
  • A monthly overview on key updates with analysis offered for each of the different sub-categories of Diagnostics/Devices Advances such as Global Grants/Funding, Licensing, Manufacturing/Development/Production, Regulatory Approvals, Research/Studies, Technology Updates, Testing, and Testing Kits/Facilities/Sites

For more information about this report visit https://www.researchandmarkets.com/r/u4nian

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Research and Markets


Release Versions

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

More News From Research and Markets

Philippines Colocation Data Center Portfolio Report 2025-2028: Key Locations, Existing & Upcoming White-Floor Space, Current and Future IT Load Capacity, Wholesale and Retail Colocation Pricing - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Philippines Existing & Upcoming Data Center Portfolio" database has been added to ResearchAndMarkets.com's offering. Philippines hosts around 28 existing data centers, with Manila having the strongest presence in the country. Manila remains the dominant data center hub in the Philippines, hosting the majority of existing and upcoming facilities, while Cavite is rapidly emerging as a secondary growth cluster. The Philippines Upcoming data center market is enteri...

Malaysia Colocation Data Center Portfolio Report 2025-2028: Detailed Analysis of 46 Existing Data Centers, 46 Upcoming Data Centers, and 42 Major Operators/Investors - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Malaysia Existing & Upcoming Data Center Portfolio" database has been added to ResearchAndMarkets.com's offering. Malaysia hosts around 46 existing data centers, with cities like Iskandar Puteri, Sedenak, Cyberjaya and Johor having a strong presence in the region. A significant number of facilities have come online between 2024 and 2025, including KL1 and JH1 from Equinix and JHB1 from Airtrunk. Bridge Data Centres, GDS Services, and YTL Data Center Holdings co...

Indonesia Colocation Data Center Portfolio Report 2025-2028: Detailed Analysis of 86 Existing Data Centers, 23 Upcoming Data Centers, and 36 Major Operators/Investors - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Indonesia Existing & Upcoming Data Center Portfolio" database has been added to ResearchAndMarkets.com's offering. Indonesia hosts around 85+ existing data centers, with regions like Jakarta and West Java having a strong presence in the country. Jakarta dominates Indonesia's upcoming data center market, with an estimated power capacity of around 450 MW. While Jakarta continues to lead in capacity and development activity, Batam is emerging as a significant seco...
Back to Newsroom